Keywords
DrugDrug discoveryCancerDrug developmentCancer drugsCancer cell linesAnticancer drugMedicineCancer chemotherapyCancer researchCancer cellPharmacologyBiologyBioinformaticsInternal medicine
Affiliated Institutions
Related Publications
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
Since 1990, the National Cancer Institute (NCI) has screened more than 60,000 compounds against a panel of 60 human cancer cell lines. The 50-percent growth-inhibitory concentra...
Tumor angiogenesis: past, present and the near future
The concept of treating solid tumors by inhibiting tumor angiogenesis was first articulated almost 30 years ago. For the next 10 years it attracted little scientific interest. T...
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Cancer is one of the main causes of death worldwide. Despite the significant development of methods of cancer healing during the past decades, chemotherapy still remains the mai...
Organoids in cancer research
The recent advances in in vitro 3D culture technologies, such as organoids, have opened new avenues for the development of novel, more physiological human cancer models. Such pr...
Targeting apoptosis in cancer therapy
For over three decades, a mainstay and goal of clinical oncology has been the development of therapies promoting the effective elimination of cancer cells by apoptosis. This pro...
Publication Info
- Year
- 2006
- Type
- review
- Volume
- 6
- Issue
- 10
- Pages
- 813-823
- Citations
- 2602
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2602
OpenAlex
Cite This
Robert H. Shoemaker
(2006).
The NCI60 human tumour cell line anticancer drug screen.
Nature reviews. Cancer
, 6
(10)
, 813-823.
https://doi.org/10.1038/nrc1951
Identifiers
- DOI
- 10.1038/nrc1951